Dina Masi
2020
In 2020, Dina Masi earned a total compensation of $254.3K as Chief Financial Officer and Senior Vice President at Integrated Biopharma, a 1% increase compared to previous year.
Compensation breakdown
| Bonus | $10,000 |
|---|---|
| Option Awards | $3,675 |
| Salary | $231,447 |
| Other | $9,200 |
| Total | $254,322 |
Masi received $231.4K in salary, accounting for 91% of the total pay in 2020.
Masi also received $10K in bonus, $3.7K in option awards and $9.2K in other compensation.
Rankings
In 2020, Dina Masi's compensation ranked 12,335th out of 13,090 executives tracked by ExecPay. In other words, Masi earned more than 5.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,335 out of 13,090 | 6th |
Division Manufacturing | 5,284 out of 5,618 | 6th |
Major group Chemicals And Allied Products | 2,141 out of 2,251 | 5th |
Industry group Drugs | 1,860 out of 1,951 | 5th |
Industry Pharmaceutical Preparations | 1,382 out of 1,456 | 5th |
Source: SEC filing on October 27, 2021.
Masi's colleagues
We found three more compensation records of executives who worked with Dina Masi at Integrated Biopharma in 2020.
News
Integrated Biopharma CFO Dina Masi's 2024 pay rises 8% to $357K
October 28, 2024
Integrated Biopharma CFO Dina Masi's 2023 pay rises 10% to $330K
October 27, 2023
Integrated Biopharma CFO Dina Masi's 2022 pay rises 12% to $300K
October 27, 2022
Integrated Biopharma CFO Dina Masi's 2021 pay rises 6% to $268K
October 27, 2021
Integrated Biopharma CFO Dina Masi's 2019 pay rises 4% to $251K
October 28, 2019